Apyx Medical (APYX) EPS (Weighted Average and Diluted) (2016 - 2024)
Historic EPS (Weighted Average and Diluted) for Apyx Medical (APYX) over the last 14 years, with Q2 2024 value amounting to -$0.19.
- Apyx Medical's EPS (Weighted Average and Diluted) fell 53333.33% to -$0.19 in Q2 2024 from the same period last year, while for Jun 2024 it was -$0.82, marking a year-over-year decrease of 7446.81%. This contributed to the annual value of -$0.54 for FY2023, which is 1932.92% up from last year.
- According to the latest figures from Q2 2024, Apyx Medical's EPS (Weighted Average and Diluted) is -$0.19, which was down 53333.33% from -$0.22 recorded in Q1 2024.
- In the past 5 years, Apyx Medical's EPS (Weighted Average and Diluted) ranged from a high of -$0.03 in Q2 2023 and a low of -$0.28 during Q4 2023
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.14 (2020), whereas its average is -$0.14.
- In the last 5 years, Apyx Medical's EPS (Weighted Average and Diluted) skyrocketed by 8125.0% in 2023 and then crashed by 53333.33% in 2024.
- Apyx Medical's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.05 in 2020, then decreased by 20.0% to -$0.06 in 2021, then plummeted by 183.33% to -$0.17 in 2022, then crashed by 63.23% to -$0.28 in 2023, then surged by 31.53% to -$0.19 in 2024.
- Its EPS (Weighted Average and Diluted) stands at -$0.19 for Q2 2024, versus -$0.22 for Q1 2024 and -$0.28 for Q4 2023.